Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · Real-Time Price · USD
22.04
+0.34 (1.57%)
Jan 7, 2025, 3:19 PM EST - Market open
IART Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for IART stock have an average target of 24.67, with a low estimate of 18 and a high estimate of 35. The average target predicts an increase of 11.93% from the current stock price of 22.04.
Analyst Consensus: Sell
* Price targets were last updated on Nov 5, 2024.
Analyst Ratings
The average analyst rating for IART stock from 7 stock analysts is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Hold | 2 | 2 | 2 | 3 | 3 | 3 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 2 | 2 | 2 | 1 | 1 | 1 |
| Total | 9 | 9 | 9 | 9 | 9 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Sell Maintains $16 → $22 | Strong Sell | Maintains | $16 → $22 | -0.18% | Nov 5, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $26 → $21 | Hold | Maintains | $26 → $21 | -4.72% | Oct 14, 2024 |
| B of A Securities | B of A Securities | Sell Maintains $26 → $18 | Sell | Maintains | $26 → $18 | -18.33% | Oct 7, 2024 |
| BTIG | BTIG | Strong Sell → Hold Upgrades n/a | Strong Sell → Hold | Upgrades | n/a | n/a | Oct 7, 2024 |
| Citigroup | Citigroup | Strong Sell Maintains $20 → $16 | Strong Sell | Maintains | $20 → $16 | -27.40% | Oct 1, 2024 |
Financial Forecast
Revenue This Year
1.65B
from 1.54B
Increased by 6.71%
Revenue Next Year
1.75B
from 1.65B
Increased by 6.20%
EPS This Year
2.50
from 0.84
Increased by 197.64%
EPS Next Year
2.56
from 2.50
Increased by 2.56%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 1.7B | 1.8B | 1.9B | |
| Avg | 1.6B | 1.7B | 1.8B | |
| Low | 1.6B | 1.7B | 1.7B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 10.1% | 9.8% | 8.1% | |
| Avg | 6.7% | 6.2% | 4.4% | |
| Low | 2.4% | 1.2% | -0.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 2.60 | 2.76 | 3.16 | |
| Avg | 2.50 | 2.56 | 2.84 | |
| Low | 2.38 | 2.37 | 2.61 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 209.3% | 10.5% | 23.3% | |
| Avg | 197.6% | 2.6% | 10.6% | |
| Low | 183.5% | -5.1% | 1.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.